Literature DB >> 8592343

Autosomal dominant retinitis pigmentosa locus on chromosome 19q in a Japanese family.

S Xu1, M Nakazawa, M Tamai, A Gal.   

Abstract

A large four generation Japanese family was studied, in which autosomal dominant retinitis pigmentosa (ADRP) of very variable expression was segregating. Positive lod scores with maxima between 1.557-5.118 at theta = 0.00, strongly suggestive of linkage, were obtained for KLK, D19S180, D19S418, and D19S254 on chromosome 19q. Recently, an ADRP locus has been mapped to the same region in a British family, in which, again, several members subjectively had no clinical evidence of the disease although they had both an affected parent and an affected child.

Entities:  

Mesh:

Year:  1995        PMID: 8592343      PMCID: PMC1051751          DOI: 10.1136/jmg.32.11.915

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  5 in total

1.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

2.  Integrated human genome-wide maps constructed using the CEPH reference panel.

Authors:  K H Buetow; J L Weber; S Ludwigsen; T Scherpbier-Heddema; G M Duyk; V C Sheffield; Z Wang; J C Murray
Journal:  Nat Genet       Date:  1994-04       Impact factor: 38.330

3.  Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19.

Authors:  M al-Maghtheh; C F Inglehearn; T J Keen; K Evans; A T Moore; M Jay; A C Bird; S S Bhattacharya
Journal:  Hum Mol Genet       Date:  1994-02       Impact factor: 6.150

4.  Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study.

Authors:  A T Moore; F Fitzke; M Jay; G B Arden; C F Inglehearn; T J Keen; S S Bhattacharya; A C Bird
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

5.  A new locus for autosomal dominant retinitis pigmentosa on the short arm of chromosome 17.

Authors:  J Greenberg; R Goliath; P Beighton; R Ramesar
Journal:  Hum Mol Genet       Date:  1994-06       Impact factor: 6.150

  5 in total
  6 in total

Review 1.  Pre-mRNA splicing and retinitis pigmentosa.

Authors:  Daniel Mordes; Xiaoyan Luo; Amar Kar; David Kuo; Lili Xu; Kazuo Fushimi; Guowu Yu; Paul Sternberg; Jane Y Wu
Journal:  Mol Vis       Date:  2006-10-26       Impact factor: 2.367

2.  Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele.

Authors:  T L McGee; M Devoto; J Ott; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

3.  A linkage survey of 20 dominant retinitis pigmentosa families: frequencies of the nine known loci and evidence for further heterogeneity.

Authors:  C F Inglehearn; E E Tarttelin; C Plant; R E Peacock; M al-Maghtheh; E Vithana; A C Bird; S S Bhattacharya
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

4.  Mutation c. 1142 del G in the PRPF31 gene in a family with autosomal dominant retinitis pigmentosa (RP11) and its implications.

Authors:  Kurenai Taira; Mitsuru Nakazawa; Motoya Sato
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

5.  Evidence for a major retinitis pigmentosa locus on 19q13.4 (RP11) and association with a unique bimodal expressivity phenotype.

Authors:  M Al-Maghtheh; E Vithana; E Tarttelin; M Jay; K Evans; T Moore; S Bhattacharya; C F Inglehearn
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

6.  A single-base substitution within an intronic repetitive element causes dominant retinitis pigmentosa with reduced penetrance.

Authors:  Thomas Rio Frio; Terri L McGee; Nicholas M Wade; Christian Iseli; Jacques S Beckmann; Eliot L Berson; Carlo Rivolta
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.